21SEP

CuspAI closes at $2.6bn, EU fund circles

2 min read

16:52UTC

CuspAI closed in late June at $2.6bn with Bezos Expeditions and Kleiner Perkins and no UK backer; now EQT and the EU's Scaleup Europe Fund want in.

← Back to Nscale takes $103.4bn of contracts to NYSE Jump to analysis ↓

TechnologyDeveloping

Key takeaway

An EU sovereign fund is circling a UK AI winner that no British investor backed.

CuspAI's round formally closed in late June at a $2.6bn valuation, led by Bezos Expeditions and Kleiner Perkins, with no UK vehicle on the cap table ¹. The Cambridge materials-discovery firm, which uses AI to design new materials, had signed those term sheets on 20 June ; the close confirms the figure without moving it.

EQT, the Swedish investment group the European Innovation Council (the EU's deep-tech funding body) appointed to run the bloc's new €5bn Scaleup Europe Fund, then entered advanced talks for a further CuspAI stake, reported on 3 July ².

Britain spent the spring building sovereign vehicles to stop allied capital capturing its AI winners, after Fractile raised NATO and CIA venture money with no UK co-investor and Orbital Industries closed $50m with no UK lead . EQT would put an EU vehicle, not a US one, on the cap table of a company Britain's own funds passed over. The Scaleup Europe Fund holds €5bn; the UK's Sovereign AI Unit holds £500m, and has led none of the marquee 2026 rounds.

Deep Analysis

In plain English

CuspAI is a Cambridge company that uses artificial intelligence to design new materials, such as ones that capture carbon or remove harmful chemicals from water. It has just finished raising $2.6bn worth of shares from investors, but none of that money came from a British fund. Now EQT, a European investment firm managing €5bn of European Union government money, wants to buy an even bigger stake. 'No UK vehicle on the cap table' means no British-based investor owns a piece of the company. As CuspAI grows, the profits from its success will flow mostly to American and European investors rather than back into the UK.

Deep Analysis

Root Causes

The UK lacks a domestic growth-equity fund capable of writing $200m-plus cheques at Series C and beyond for deep tech. British Patient Capital, the British Business Bank's growth vehicle, is structured to allocate as a limited partner into other funds rather than write large direct cheques itself, so when a round the size of CuspAI's needs $400m in a single close, only sovereign wealth vehicles or US mega-funds have the balance sheet to supply it.

That capacity gap, not a lack of UK investor appetite, is why EQT's EU-backed fund can enter talks for a further stake while no comparable British vehicle appears on the term sheet.

What could happen next?

Precedent
EQT's pursuit of a CuspAI stake sets a template for EU sovereign vehicles buying into UK deep-tech winners at the exact cheque size domestic funds cannot match.

Source Landscape

This story draws on neutral-leaning sources

Primary parallel: ARM's 2016 sale to SoftBank showed the same mechanism at a bigger scale: a Cambridge deep-tech company with no domestic institution large enough to anchor it at its true valuation, so ownership passed abroad once the cheque size exceeded what UK growth capital could write.

Counter-parallel: Wise scaled to a London direct listing in 2021 with Baillie Gifford, a Scottish asset manager, as a top-five shareholder throughout, proving domestic capital can anchor a major scale-up when a UK institution commits early enough in the company's life, before the round sizes outgrow it.

The immediate effect is straightforward: none of CuspAI's future dividends, exit proceeds or tax receipts from a sale accrue disproportionately to UK-domiciled capital, because no UK fund holds equity to realise a gain on.

Structurally, this repeats a pattern across the fortnight's largest UK deep-tech rounds : British companies are increasingly financed by allied sovereign and foreign venture capital rather than domestic institutions, which means the country builds the technology but exports the equity upside.

Consensus view: Atomico's Tom Wehmeier, author of the annual State of European Tech report, reads EQT's Scaleup Europe Fund pursuit of CuspAI as deliberate EU industrial policy: the €5bn vehicle exists specifically to keep deep-tech winners like CuspAI anchored in Europe once a round like June's $2.6bn close shows a company can scale without a domestic lead.

Counter-view: The Startup Coalition, the UK industry body representing founders, argues the absence of a UK vehicle reflects a structural gap in domestic late-stage capital rather than EU strategy, the same gap that let the NATO Innovation Fund and In-Q-Tel into Fractile's cap table and Plural's European balance sheet into Orbital Industries with no UK fund on either.

Key tension: Whether EQT's approach substitutes for a UK vehicle that will never exist at this cheque size, or entrenches a pattern where Britain's largest deep-tech winners are permanently owned from Stockholm, Washington and Palo Alto rather than London.

First Reported In

Update #10 · AI takes record 44% as UK equity shrinks

FinSMEs / Sifted / FTI Consulting digest· 4 Jul 2026

Read original →

Causes and effects

Caused by

CuspAI raising $400m on Bezos money

CuspAI's late-June close confirms the $2.6bn valuation set when term sheets were signed on 20 June.

Occurred 20 Jun 2026

Read story →

Fractile lands NATO and CIA chip cash

Fractile's NATO/CIA-backed round with no UK co-investor set the precedent of allied capital capturing UK deep-tech upside, now repeated with EQT and CuspAI.

Occurred 13 May 2026

Read story →

Orbital's $50m raise has no UK lead

Orbital Industries' $50m round with no UK lead extended the pattern of foreign capital capturing UK deep-tech winners, now repeated with EQT's pursuit of CuspAI.

Occurred 28 May 2026

Read story →

This Event

CuspAI closes at $2.6bn, EU fund circles

If EQT closes, the upside of a UK AI winner accrues to an EU sovereign fund, the exact outcome Britain's own vehicles were built to prevent.

Led to

State fund surfaces on CuspAI cap table

The 3 July report of a round closed with no UK vehicle is contradicted by the 20 July naming of the Sovereign AI Unit as a new investor.

Occurred 20 Jul 2026

Read story →

Different Perspectives

Nscale and Open Cosmos

Nscale chose the New York Stock Exchange for its listing on 18 September, putting Britain's largest AI infrastructure bet to American public investors rather than British ones. Open Cosmos took the opposite route four days earlier, raising nine figures from an all-domestic syndicate on five years of profit, evidence that staying is possible when the balance sheet allows it.

Dame Chi Onwurah and the Science, Innovation and Technology Committee

Committee chair Dame Chi Onwurah wrote to government on 7 September asking how Matt Clifford's conflict at ARIA arose and what safeguards protect its governance, and expects a detailed response. Her question has not yet been put to the Sovereign AI Unit, whose own chair sits at a venture capital firm while overseeing state AI equity.

The Entrepreneurs Network

The Entrepreneurs Network's founder survey found 65% say Britain is easy to start a business in but only 14% say it is easy to scale one, with 82% negative on tax and 74% finding investment hard to access. On this reading the constraint is regulation and tax, not the capital-vehicle design the state keeps adjusting.

New Economics Foundation

The New Economics Foundation argues fiscal accounting rules, not political will, cap what Britain's state capital vehicles can do. Matching the KfW and Bpifrance benchmark of 1% of GDP would need the National Wealth Fund to deploy roughly GBP21bn a year by 2028-29, about four times its current capacity.

Competition and Markets Authority

The CMA's 8 September report on public procurement asked whether Britain's roughly GBP400bn state-spending system is built to grow high-potential firms rather than simply widen SME participation. Its Recommendation 5 calls for a dedicated frontier-technology procurement framework, an official acknowledgement that today's design may serve the wrong target.

Highland Europe

Highland Europe, the growth-equity firm behind a €1bn-plus fund, took €65m from the British Business Bank into its Technology Growth Fund VI on 30 July via British Patient Capital. For a Geneva-based growth investor, the Bank's cheque is routine cornerstone capital, unrelated to which Whitehall department currently claims to sponsor UKRI.